Core Scientific Ownership
| CORZ Stock | USD 17.14 0.46 2.76% |
Core Stock Ownership Analysis
About 97.0% of the company shares are held by institutions such as insurance companies. The company recorded a loss per share of 2.16. Core Scientific Common had not issued any dividends in recent years. Core Scientific, Inc. operates facilities for digital asset mining and colocation services in North America. It also develops blockchain-based platforms and applications, including infrastructure management, security technologies, mining optimization, and recordkeeping. Core Scientific operates under SoftwareInfrastructure classification in the United States and is traded on NASDAQ Exchange. It employs 205 people. For more info on Core Scientific Common please contact Adam Sullivan at 512 402 5233 or go to https://corescientific.com.Besides selling stocks to institutional investors, Core Scientific also allocates a substantial amount of its earnings to a pull of share-based compensation to be paid out to its employees, managers, executives, and members of the board of directors. Share-Based compensation (also sometimes called Stock-Based Compensation) is a way of paying different Core Scientific's stakeholders with equity in the business. It is typically used as a motivation factor for employees to contribute beyond their regular compensation (salary and bonus). It is also used as a tool to align Core Scientific's strategic interests with those of the company's shareholders. Shares issued to employees are usually subject to a vesting period before they are earned and sold.
Core Scientific Quarterly Liabilities And Stockholders Equity |
|
Core Scientific Insider Trades History
Roughly 3.0% of Core Scientific Common are currently held by insiders. Unlike Core Scientific's institutional investors, corporate insiders most likely have a limit on the maximum percentage of share ownership. This is done to align insiders' influence against Core Scientific's private investors even though both sides will benefit from rising prices or experience loss when the share price declines. The good rule to have in mind is that the maximum share ownership percentage of the corporate insiders should not surpass 25%. View all of Core Scientific's insider trades
Core Scientific Common Insider Trading Activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Core Scientific insiders, such as employees or executives, is commonly permitted as long as it does not rely on Core Scientific's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Core Scientific insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Core Scientific Outstanding Bonds
Core Scientific issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Core Scientific Common uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Core bonds can be classified according to their maturity, which is the date when Core Scientific Common has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| CoreCivic 475 percent Corp BondUS21871NAA90 | View | |
| US21871DAD57 Corp BondUS21871DAD57 | View |
Core Scientific Corporate Filings
13A | 7th of January 2026 An amended filing to the original Schedule 13G | ViewVerify |
F4 | 5th of January 2026 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
F3 | 18th of December 2025 An amendment to the original Schedule 13D filing | ViewVerify |
13A | 14th of November 2025 The form used by investors holding more than 5% of a company's stock, to report their beneficial ownership pursuant to Rule 13d-1 or Rule 13d-2 under the Securities Exchange Act of 1934 | ViewVerify |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Core Stock Analysis
When running Core Scientific's price analysis, check to measure Core Scientific's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Core Scientific is operating at the current time. Most of Core Scientific's value examination focuses on studying past and present price action to predict the probability of Core Scientific's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Core Scientific's price. Additionally, you may evaluate how the addition of Core Scientific to your portfolios can decrease your overall portfolio volatility.